Cargando…
Techniques for estimating health care costs with censored data: an overview for the health services researcher
OBJECTIVE: The aim of this study was to review statistical techniques for estimating the mean population cost using health care cost data that, because of the inability to achieve complete follow-up until death, are right censored. The target audience is health service researchers without an advance...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377439/ https://www.ncbi.nlm.nih.gov/pubmed/22719214 http://dx.doi.org/10.2147/CEOR.S31552 |
_version_ | 1782235957856043008 |
---|---|
author | Wijeysundera, Harindra C Wang, Xuesong Tomlinson, George Ko, Dennis T Krahn, Murray D |
author_facet | Wijeysundera, Harindra C Wang, Xuesong Tomlinson, George Ko, Dennis T Krahn, Murray D |
author_sort | Wijeysundera, Harindra C |
collection | PubMed |
description | OBJECTIVE: The aim of this study was to review statistical techniques for estimating the mean population cost using health care cost data that, because of the inability to achieve complete follow-up until death, are right censored. The target audience is health service researchers without an advanced statistical background. METHODS: Data were sourced from longitudinal heart failure costs from Ontario, Canada, and administrative databases were used for estimating costs. The dataset consisted of 43,888 patients, with follow-up periods ranging from 1 to 1538 days (mean 576 days). The study was designed so that mean health care costs over 1080 days of follow-up were calculated using naïve estimators such as full-sample and uncensored case estimators. Reweighted estimators – specifically, the inverse probability weighted estimator – were calculated, as was phase-based costing. Costs were adjusted to 2008 Canadian dollars using the Bank of Canada consumer price index (http://www.bankofcanada.ca/en/cpi.html). RESULTS: Over the restricted follow-up of 1080 days, 32% of patients were censored. The full-sample estimator was found to underestimate mean cost ($30,420) compared with the reweighted estimators ($36,490). The phase-based costing estimate of $37,237 was similar to that of the simple reweighted estimator. CONCLUSION: The authors recommend against the use of full-sample or uncensored case estimators when censored data are present. In the presence of heavy censoring, phase-based costing is an attractive alternative approach. |
format | Online Article Text |
id | pubmed-3377439 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-33774392012-06-20 Techniques for estimating health care costs with censored data: an overview for the health services researcher Wijeysundera, Harindra C Wang, Xuesong Tomlinson, George Ko, Dennis T Krahn, Murray D Clinicoecon Outcomes Res Review OBJECTIVE: The aim of this study was to review statistical techniques for estimating the mean population cost using health care cost data that, because of the inability to achieve complete follow-up until death, are right censored. The target audience is health service researchers without an advanced statistical background. METHODS: Data were sourced from longitudinal heart failure costs from Ontario, Canada, and administrative databases were used for estimating costs. The dataset consisted of 43,888 patients, with follow-up periods ranging from 1 to 1538 days (mean 576 days). The study was designed so that mean health care costs over 1080 days of follow-up were calculated using naïve estimators such as full-sample and uncensored case estimators. Reweighted estimators – specifically, the inverse probability weighted estimator – were calculated, as was phase-based costing. Costs were adjusted to 2008 Canadian dollars using the Bank of Canada consumer price index (http://www.bankofcanada.ca/en/cpi.html). RESULTS: Over the restricted follow-up of 1080 days, 32% of patients were censored. The full-sample estimator was found to underestimate mean cost ($30,420) compared with the reweighted estimators ($36,490). The phase-based costing estimate of $37,237 was similar to that of the simple reweighted estimator. CONCLUSION: The authors recommend against the use of full-sample or uncensored case estimators when censored data are present. In the presence of heavy censoring, phase-based costing is an attractive alternative approach. Dove Medical Press 2012-06-01 /pmc/articles/PMC3377439/ /pubmed/22719214 http://dx.doi.org/10.2147/CEOR.S31552 Text en © 2012 Wijeysundera et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Review Wijeysundera, Harindra C Wang, Xuesong Tomlinson, George Ko, Dennis T Krahn, Murray D Techniques for estimating health care costs with censored data: an overview for the health services researcher |
title | Techniques for estimating health care costs with censored data: an overview for the health services researcher |
title_full | Techniques for estimating health care costs with censored data: an overview for the health services researcher |
title_fullStr | Techniques for estimating health care costs with censored data: an overview for the health services researcher |
title_full_unstemmed | Techniques for estimating health care costs with censored data: an overview for the health services researcher |
title_short | Techniques for estimating health care costs with censored data: an overview for the health services researcher |
title_sort | techniques for estimating health care costs with censored data: an overview for the health services researcher |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377439/ https://www.ncbi.nlm.nih.gov/pubmed/22719214 http://dx.doi.org/10.2147/CEOR.S31552 |
work_keys_str_mv | AT wijeysunderaharindrac techniquesforestimatinghealthcarecostswithcensoreddataanoverviewforthehealthservicesresearcher AT wangxuesong techniquesforestimatinghealthcarecostswithcensoreddataanoverviewforthehealthservicesresearcher AT tomlinsongeorge techniquesforestimatinghealthcarecostswithcensoreddataanoverviewforthehealthservicesresearcher AT kodennist techniquesforestimatinghealthcarecostswithcensoreddataanoverviewforthehealthservicesresearcher AT krahnmurrayd techniquesforestimatinghealthcarecostswithcensoreddataanoverviewforthehealthservicesresearcher |